98%
921
2 minutes
20
Introduction: The molecular and histological characteristics of primary duodenal adenocarcinoma (DA) have been poorly described, which hampers the development of new treatment options. This study aimed to characterize the landscape of chromosomal copy number aberrations (CNAs), microsatellite instability status, and tumor-stroma content, and their association with clinicopathological characteristics of patients with DA.
Methods: DNA was extracted from tumor tissues of patients who underwent a primary surgical resection for DA in a single center (2000-2019). Shallow whole genome sequencing (sWGS) was performed to identify chromosomal CNAs and the genomic instability index (GII), for which 25% of the genome was altered, was used to classify tumors as CNA or CNA. A PCR-based assay was performed to classify tumors as microsatellite stable (MSS) or instable (MSI). Immunohistochemistry and digital image analysis were performed to determine the tumor-stroma content, for which 50% stroma content was used to classify tumors as stroma or stroma.
Results: Among 74 patients with resected DA, sWGS identified 39 (52.7%) CNA and 35 (47.3%) CNA tumors. Overall, 16 (21.6%) DAs were MSI. All MSI tumors were CNA. The tumor-stroma content was low in 51 (68.9%) and high in 23 (31.1%) of DAs. CNA status was most predictive for 5-year overall survival: 45.5% for patients with CNA compared to 31.0% for patients with CNA DA (HR 2.20, 95% CI 1.12-4.30, p = 0.02).
Conclusion: About half of resected DAs had CNA, which was associated with the most favorable prognosis. Subgrouping of DA could be used for patient stratification in future trials testing novel therapies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12254436 | PMC |
http://dx.doi.org/10.1002/gcc.70061 | DOI Listing |
J Pathol Clin Res
July 2025
Department of Medical Biosciences, Building 6M, Umeå University, Umeå, Sweden.
Squamous cell carcinoma of the oral tongue (SCCOT) represents an aggressive malignancy characterized by high metastatic potential and significant heterogeneity in its tumor microenvironment. The tumor-stroma ratio (TSR) has emerged as a prognostic biomarker, with higher stromal content frequently correlating with worse survival outcomes. Traditional approaches using the standard 50% TSR cutoff may not be optimal for SCCOT, and visual TSR estimation introduces variability during TSR region annotation.
View Article and Find Full Text PDFFront Immunol
July 2025
Department of Cancer Drug Discovery and Development, Research Center, Osaka International Cancer Institute, Osaka, Japan.
Introduction: Chimeric antigen receptor (CAR)-T cell therapy has demonstrated notable efficacy in treating hematological malignancies. Although it has shown promise in the clinical management of solid tumors, poor outcomes in clinical trials highlight the challenges in developing therapies suitable for the distinct tumor microenvironment, which features a dense stroma composed of fibroblasts and extracellular matrix proteins, such as collagen, hyaluronan, proteoglycans, laminin, and elastin. These predominantly fibroblast-produced components create a barrier that can impede CAR-T cell infiltration into tumors, limiting their efficacy.
View Article and Find Full Text PDFGenes Chromosomes Cancer
July 2025
Department of Surgery, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands.
Introduction: The molecular and histological characteristics of primary duodenal adenocarcinoma (DA) have been poorly described, which hampers the development of new treatment options. This study aimed to characterize the landscape of chromosomal copy number aberrations (CNAs), microsatellite instability status, and tumor-stroma content, and their association with clinicopathological characteristics of patients with DA.
Methods: DNA was extracted from tumor tissues of patients who underwent a primary surgical resection for DA in a single center (2000-2019).
Ann Med Surg (Lond)
June 2025
Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe.
Iron metabolism plays a crucial role in breast cancer progression by supporting rapid cell proliferation, metastasis, and therapy resistance. Breast cancer cells exhibit increased iron uptake through overexpression of transferrin receptor 1, leading to intracellular iron accumulation. Elevated ferritin levels further protect tumor cells from oxidative stress-induced damage, while reduced ferroportin expression limits iron export, creating an iron-rich microenvironment that favors tumorigenesis.
View Article and Find Full Text PDFOral Dis
July 2025
Institute of Biomedicine, Pathology, University of Turku, Turku, Finland.
Background: This article aims to provide a broad overview of the oral squamous cell carcinoma (OSCC) tumor stroma, describing and discussing recent advances in the understanding of different stromal elements and their roles in tumor progression. We also describe potential new therapeutic approaches targeting the stroma.
Methods: A literature review on the role of stromal biomarkers in OSCC was conducted.